EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration

Umair Majid, Christian Holst Bergsland, Anita Sveen, Jarle Bruun, Ina Andrassy Eilertsen, Espen S Bækkevold, Arild Nesbakken, Sheraz Yaqub, Frode L Jahnsen, Ragnhild A Lothe

Cellular Oncology · 2024-08 · 47 (4) · 1267-1276

DOI: 10.1007/s13402-024-00926-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 26.02.2024. Verfasst von Umair Majid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor-Associated Macrophages, Lymphocytes, Tumor-Infiltrating, Neoplasm Staging. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kreftforeningen, Helse Sør-Øst RHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor-associated macrophages (TAMs) are associated with unfavorable patient prognosis in many cancer types. However, TAMs are a heterogeneous cell population and subsets have been shown to activate tumor-infiltrating T cells and confer a good patient prognosis. Data on the prognostic value of TAMs in colorectal cancer are conflicting. We investigated the prognostic effect of TAMs in relation to tumor-infiltrating T cells in colorectal cancers.

Methods

The TAM markers CD68 and CD163 were analyzed by multiplex fluorescence immunohistochemistry and digital image analysis on tissue microarrays of 1720 primary colorectal cancers. TAM density in the tumor stroma was scored in relation to T cell density (stromal CD3 + and epithelial CD8 + cells) and analyzed in Cox proportional hazards models of 5-year relapse-free survival. Multivariable survival models included clinicopathological factors, MSI status and BRAF V600E mutation status.

Results

High TAM density was associated with a favorable 5-year relapse-free survival in a multivariable model of patients with stage I–III tumors ( p = 0.004, hazard ratio 0.94, 95% confidence interval 0.90–0.98). However, the prognostic effect was dependent on tumoral T-cell density. High TAM density was associated with a good prognosis in patients who also had high T-cell levels in their tumors, while high TAM density was associated with poorer prognosis in patients with low T-cell levels ( p interaction = 0.0006). This prognostic heterogeneity was found for microsatellite stable tumors separately.

Conclusions

This study supported a phenotypic heterogeneity of TAMs in colorectal cancer, and showed that combined tumor immunophenotyping of multiple immune cell types improved the prediction of patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor-Associated MacrophagesLymphocytes, Tumor-InfiltratingNeoplasm StagingHumansMaleFemalePrognosisMiddle AgedAgedT-LymphocytesAntigens, CDAntigens, Differentiation, MyelomonocyticAdultAged, 80 and overProportional Hazards Models

Stichwörter der Autor:innen

Colorectal cancerImmune tumor microenvironmentMultiplex fluorescence immunohistochemistryPrognostic markersT cellsTumor associated macrophages

Substanzen

Antigens, CDAntigens, Differentiation, Myelomonocytic

Autor:innen und Institutionen

  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Pathology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
  • Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Institute of Oral Biology, University of Oslo, Oslo, Norway.
  • Department of Hepatobiliary Surgery, Oslo University Hospital, Oslo, Norway.
  • Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. r.a.lothe@medisin.uio.no.

Förderung

  • Kreftforeningen
  • Helse Sør-Øst RHF

Zitieren

APA

Majid, U., Bergsland, C. H., Sveen, A., Bruun, J., Eilertsen, I. A., Bækkevold, E. S., Nesbakken, A., Yaqub, S., Jahnsen, F. L., & Lothe, R. A. (2024). The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration. Cellular Oncology, 47(4), 1267-1276. https://doi.org/10.1007/s13402-024-00926-w

Vancouver

Majid U, Bergsland CH, Sveen A, Bruun J, Eilertsen IA, Bækkevold ES, et al. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration. Cellular Oncology. 2024;47(4):1267-1276. doi:10.1007/s13402-024-00926-w

BibTeX
@article{Majid2024,
  author = {Majid, Umair and Bergsland, Christian Holst and Sveen, Anita and Bruun, Jarle and Eilertsen, Ina Andrassy and Bækkevold, Espen S and Nesbakken, Arild and Yaqub, Sheraz and Jahnsen, Frode L and Lothe, Ragnhild A},
  title = {The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration},
  journal = {Cellular Oncology},
  year = {2024},
  volume = {47},
  number = {4},
  pages = {1267--1276},
  doi = {10.1007/s13402-024-00926-w}
}
Kostenlos starten →